AI continues to make inroads in healthcare. Digitalisation and the use of AI were prominent topics in nearly every panel discussion at the recent HBI 2024 conference, held from June 10 to 12, with 580 delegates from 40 countries in attendance.
German Health Minister Karl Lauterbach’s intention to ban investors from owning outpatient facilities appears to no longer have any realistic chance of being passed. Investors and advisors are consequently gearing up for a flurry of deals in H2 from pent-up demand.
The Competition and Markets Authority (CMA) has announced the launch of a full-scale investigation into the UK’s veterinary sector, following a sizeable response to its initial review in September 2023. The initial review generated 56,000 responses from pet owners and professionals, prompting the authority to launch a market investigation.
Mid Europa Partners, a central and eastern Europe-focused PE investor, is selling Regina Maria, Romania’s second largest private health care provider by revenue, after almost a decade of ownership. Turkish group Acibadem is rumoured to be likely to bid, although the group would not confirm this to HBI.
It seems a week doesn’t go by without an M&A story involving India’s healthcare sector. Given this rapidly evolving landscape, what is the latest lie of the land?
Two major Polish hospital groups are set to merge and become the country’s largest private provider. American Heart of Poland, the country’s second largest group by revenue, is acquiring Scanmed, a slightly smaller group. The price of the deal is reportedly around €400m.
Multinational French care home giant emeis has finalised a deal to sell eleven nursing homes in the Netherlands to Bouwinvest. The transaction was valued at €97 million.
French PE firm PAI Partners will become the new owner of Fresenius Vamed’s rehab business. Vamed is currently a subsidiary of German health care conglomerate Fresenius, who will continue to hold a minority stake.
Fullerton Health Corporation Limited (Fullerton Health), a multinational occupational health care provider in the Asia-Pacific region, confirmed on Tuesday that pharmaceutical company Far East Drug (B.V.I.) Co. Ltd (FED) is acquiring a significant stake in the Singapore-headquartered group.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.